Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| 10-K | 10-K | 10-K | 10-K |
Revenues: |
United States | 78.6 | 106.3 | 91.1 | 40.0 |
Other | 21.9 | 10.2 | 4.8 | 0.4 |
Total revenues | 100.5 | 116.6 | 95.9 | 40.4 |
Revenue growth [+] | -13.8% | 21.6% | 137.2% | |
United States | -26.1% | 16.8% | 127.6% | |
Other | 113.6% | 113.6% | 1086.6% | |
Cost of goods sold | 58.7 | 68.4 | 57.3 | 27.1 |
Gross profit | 41.8 | 48.2 | 38.6 | 13.3 |
Gross margin | 41.6% | 41.3% | 40.2% | 33.0% |
Selling, general and administrative [+] | 58.8 | 53.2 | 31.3 | 16.1 |
Sales and marketing | 43.6 | 40.1 | 25.2 | 12.8 |
General and administrative | 15.2 | 13.1 | 6.1 | 3.3 |
Research and development | 36.1 | 32.6 | 18.4 | 13.0 |
Other operating expenses | | | | 0.4 |
EBITDA [+] | -49.5 | -34.9 | -9.4 | -14.8 |
EBITDA growth | 42.0% | 271.4% | -36.7% | |
EBITDA margin | -49.3% | -29.9% | -9.8% | -36.7% |
Depreciation and amortization | 3.6 | 2.7 | 1.8 | 1.4 |
EBIT [+] | -53.1 | -37.6 | -11.2 | -16.2 |
EBIT growth | 41.2% | 236.0% | -30.9% | |
EBIT margin | -52.8% | -32.2% | -11.7% | -40.1% |
Non-recurring items | 5.3 | | | |
Interest expense | 0.5 | 0.4 | 0.0 | |
Interest expense | 0.5 | 0.4 | 0.0 | |
Other income (expense), net [+] | 0.0 | -2.6 | -5.3 | 0.3 |
Gain (loss) on derivative instruments | -4.7 | | | |
Other | 0.0 | -2.6 | -5.3 | 0.3 |
Pre-tax income | -58.9 | -40.6 | -16.6 | -15.9 |
Income taxes | 0.3 | 0.1 | 0.0 | 0.0 |
Net income | -59.2 | -40.7 | -16.6 | -15.9 |
Net margin | -58.9% | -34.9% | -17.3% | -39.3% |
|
Basic EPS [+] | ($1.14) | ($1.22) | ($4.45) | ($6.58) |
Growth | -6.2% | -72.6% | -32.4% | |
Diluted EPS [+] | ($1.14) | ($1.22) | ($4.45) | ($6.58) |
Growth | -6.2% | -72.6% | -32.4% | |
|
Shares outstanding (basic) [+] | 47.0 | 30.8 | 2.5 | 2.4 |
Growth | 52.3% | 1126.1% | 5.0% | |
Shares outstanding (diluted) [+] | 47.0 | 30.8 | 2.5 | 2.4 |
Growth | 52.3% | 1126.1% | 5.0% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|